Description
Operator of a biotechnology company specializing in peripheral nerve repair. The company designs, develops and commercializes technology that aligns and seals nerves severed by disease, traumatic events or surgical procedures, overcoming complications from the misdirection and loss of axons.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Christopher Gladin Ph.D | Chief Executive Officer |